The glucagon receptors known role in hepatic lipid handling makes this a mechanistically plausible avenue, and dedicated studies in this area are anticipated
But the primary driver for most tesamorelin prescriptions is visceral fat reduction: this is where this peptide genuinely outperforms its alternatives
However, many patients find that high-fat, high-sugar, or heavily processed foods trigger nausea, fullness discomfort, or digestive distressnot because the drug forbids them, but because your brain now recognizes satiety signals more clearly
Early findings suggest reduced cravings and improved impulse control in some patients, although this area continues to be studied and is not yet considered a standard treatment for addiction
Funded by WW International, Inc